Research map: Translating the gut microbiome: where are we?

Back to the article

Papers in this map

  1. Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors · Bertrand Routy · 2017 · 5713 citations · Cited by this paper
  2. Dupilumab versus placebo in adults and adolescents with eosinophilic gastritis (DEGAS): a double-blind, placebo-controlled, phase 2, multicentre, randomised controlled trial · 2026 · Related
  3. Interaction between drugs and the gut microbiome · Rinse Karel Weersma · 2020 · 972 citations · Cited by this paper
  4. Ethnicity, diversity, and inclusion in gastroenterology: from representation to system performance · 2026 · Related
  5. Microbiome confounders and quantitative profiling challenge predicted microbial targets in colorectal cancer development · Raul Yhossef Tito · 2024 · 140 citations · Cited by this paper
  6. Cyclic exclusive enteral nutrition in paediatric Crohn's disease – Authors’ reply · 2026 · Related
  7. International consensus statement on microbiome testing in clinical practice · Serena Porcari · 2024 · 102 citations · Cited by this paper
  8. Rome V: refining the language of gut–brain disorders · 2026 · Related
  9. Dysbiosis and Associated Stool Features Improve Prediction of Response to Biological Therapy in Inflammatory Bowel Disease · Clara Caenepeel · 2023 · 89 citations · Cited by this paper
  10. The spectrum of steatotic liver disease in the USA – Authors’ reply · 2026 · Related
  11. Fine-tuning the gut ecosystem: the current landscape and outlook of artificial microbiome therapeutics · Serena Porcari · 2024 · 41 citations · Cited by this paper
  12. Drugging the undruggable in pancreatic cancer · 2026 · Related
  13. Gut microbiome composition is associated with long-term disability worsening in multiple sclerosis · Lindsay Devolder · 2023 · 23 citations · Cited by this paper
  14. Pathophysiology of irritable bowel syndrome · 2026 · Related
  15. Host factors dictate gut microbiome alterations in chronic kidney disease more strongly than kidney function · Hubert Krukowski · 2026 · 13 citations · Cited by this paper
  16. Therapeutic drift or formulation drift: avoiding misconceptions about rifaximin and antimicrobial resistance in cirrhosis · 2026 · Related
  17. Pasteurized Akkermansia muciniphila MucT for weight loss maintenance in people with overweight and obesity: a controlled randomized trial · Sarah Mount · 2026 · 13 citations · Cited by this paper
  18. Combination therapy in metabolic dysfunction-associated steatohepatitis · 2026 · Related
  19. The role of fecal microbiota transplantation in diabetes · Gabriele Angelo Vassallo · 2025 · 12 citations · Cited by this paper
  20. The small interfering RNA imdusiran as single and multiple doses in healthy, randomised individuals and non-randomised individuals with chronic hepatitis B (AB-729–001): a phase 1a/b trial · 2026 · Related
  21. CTIM-15. EO2401 PEPTIDE IMMUNOTHERAPY + NIVOLUMAB +/- BEVACIZUMAB IN FIRST RECURRENT GLIOBLASTOMA: TREATMENT STRATEGY OPTIMIZATION IN THE PHASE 1/2 STUDY EOGBM1-18 / ROSALIE (NCT04116658) · David A. Reardon · 2025 · 1 citation · Cited by this paper

Source: OpenAlex (CC0)